Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hypertension Nephrology Associates (HNA) is a specialized healthcare provider and clinical research organization focused on renal medicine and hypertensive disorders. Based in the Greater Philadelphia region, the practice manages a large patient population with chronic kidney disease (CKD) and end-stage renal disease (ESRD), providing services across outpatient clinics and dialysis centers. HNA frequently collaborates with pharmaceutical sponsors as a clinical trial site for Phase 2 through Phase 4 studies in nephrology and related cardiovascular conditions. Their clinical expertise covers complex conditions such as glomerular disease, electrolyte imbalances, and kidney transplant management. The organization plays a critical role in the local healthcare ecosystem by providing medical directorship for regional dialysis units.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hypertension Nephrology Associates.